This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Anja Hoeg
Entrepreneur in Residence at SmartRNA
Speaker

Profile

Anja Mølhart Høg leads development of smartRNA, a first-in-class, mutation-agnostic RNA therapeutics platform, designed to restore protein expression across a broad spectrum of genetic diseases. With more than 20 years of experience in RNA therapeutics, she has built deep expertise across platform innovation, drug discovery, and translational development. Prior to smartRNA, Anja served as Chief Development Officer at Heqet Therapeutics and as Chief Technology Officer at Roche Innovation Center Copenhagen, where she led RNA platform development and advanced novel oligonucleotide programs toward clinical translation. She holds a PhD in Health Sciences from the University of Copenhagen and is an inventor on 18 patent filings in oligonucleotide discovery and technology.

Agenda Sessions

  • smartRNA: A First-in-Class Scalable RNA Therapeutics Platform for Protein Upregulation

    14:00